Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Ads
      related to SBIR
    1. Sort by

    1. Press Release

      PharmiWebApr 29 01:38 PM

      The Biotechnology Innovation Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in an expanded Innovation Zone at the 2016 BIO International Convention.

    2. The Biotechnology Innovation Organization , the National Science Foundation and the National Institutes of Health today announced an agreement to feature Small Business Innovation Research -funded early-stage biomedical companies in an expanded Innovation Zone at the 2016 BIO International Convention.

    3. Oligomerix, Inc., a privately held company targeting tau oligomers for developing disease modifying therapeutics for Alzheimer’s disease and related neurodegenerative disorders, announced today the receipt of an award for a Direct-to-Phase-II Small Business Innovation Research grant for a two year program for a total of $1.5 M from the National Institutes of Health , National Institute on Aging .

    4. WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in an expanded Innovation Zone at the 2016 BIO International Convention. The Innovation Zone companies, focused on ...

    5. NH senators eye SBIR reauthorization, MEP improvements

      New Hampshire Business ReviewApr 21 10:45 AM

      Shaheen bill would make SBIR program permanent; Ayotte eyes MEP expansion

    6. NEW YORK--(BUSINESS WIRE)--Oligomerix was awarded an SBIR grant for its Alzheimer’s disease drug discovery program targeting tau oligomers from the National Institutes of Health, National Institute on Aging.

    7. Grant awarded under the Small Business Innovative Research (SBIR) Program to establish PDX/Humanized mouse platform to screen anti-cancer immunotherapies in patient-derived tumors using a novel human immune system mouse (PRWeb April 12, 2016) Read the full story at http://www.prweb.com/releases/2016/03/prweb13265364.htm

    8. Press Release

      PharmiWebMay 02 09:11 AM

      Oligomerix , Inc. Posted on: 02 May 16 Oligomerix, Inc.

    9. MOUNTAIN VIEW, Calif., April 12, 2016 /PRNewswire/ -- Cellecta, Inc. developed an approach that improves CRISPR single-guide RNA (sgRNA) designs with the successful completion of its NIH Phase I SBIR grant ...

    10. MOUNTAIN VIEW, Calif., April 12, 2016 /PRNewswire/ -- Cellecta, Inc. developed an approach that improves CRISPR single-guide RNA (sgRNA) designs with the successful completion of its NIH Phase I SBIR grant "CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform." The results move...

    1. Ads
      related to SBIR
    1. 1234560 results